Artelo Biosciences, Inc. (ARTL): Cash & Equivalents
$600.0K
As of 2025-12-31
-55.7%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $600.0K | n/a | 2026-02-24, Balance as of period end |
| No annual figure between 2022-12-31 and 2025-12-31. | |||
| 2022-12-31 | $6.89M | -43.4% | 2023-03-31, Balance as of period end |
| 2021-12-31 | $12.16M | n/a | 2023-03-31, Balance as of period end |
| 2021-08-31 | $6.63M | +209.5% | 2023-03-31, Balance as of period end |
| 2020-08-31 | $2.14M | -51.6% | 2021-11-29, Balance as of period end |
| 2019-08-31 | $4.42M | n/m | 2020-11-04, Balance as of period end |
| 2018-08-31 | $337.4K | -41.1% | 2019-12-18, Balance as of period end |
| 2017-08-31 | $572.8K | n/m | 2018-11-29, Balance as of period end |
| 2016-08-31 | $3.6K | -78.9% | 2017-11-29, Balance as of period end |
| 2015-08-31 | $17.0K | +15.6% | 2016-11-29, Balance as of period end |
| 2014-08-31 | $14.7K | n/a | 2015-12-11, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | $600.0K | n/a |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.18M | -59.8% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $58.7K | -9.5% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $2.85M | +10.1% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.18M | -33.7% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $1.39M | +26.9% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $1.11M | -27.9% |
| InMed Pharmaceuticals Inc. (INM) | 2025-06-30 | $11.08M | +68.5% |
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | $2.38M | -57.6% |
Compare ARTL, BFRG, NTHI, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗